MiniMed Group, Inc. Common Stock (MMED) - Net Assets
Based on the latest financial reports, MiniMed Group, Inc. Common Stock (MMED) has net assets worth $3.74 Billion USD as of October 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.24 Billion) and total liabilities ($491.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read MiniMed Group, Inc. Common Stock (MMED) total liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.74 Billion |
| % of Total Assets | 88.41% |
| Annual Growth Rate | -3.4% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
MiniMed Group, Inc. Common Stock - Net Assets Trend (2024–2025)
This chart illustrates how MiniMed Group, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Also explore MMED total asset value for the complete picture of this company's asset base.
Annual Net Assets for MiniMed Group, Inc. Common Stock (2024–2025)
The table below shows the annual net assets of MiniMed Group, Inc. Common Stock from 2024 to 2025. For live valuation and market cap data, see MiniMed Group, Inc. Common Stock (MMED) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-04-30 | $3.33 Billion | -3.39% |
| 2024-04-30 | $3.45 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to MiniMed Group, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (April 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Comprehensive Income | $3.00 Million | 0.09% |
| Other Components | $3.33 Billion | 99.91% |
| Total Equity | $3.33 Billion | 100.00% |
MiniMed Group, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of MiniMed Group, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
X Trade Brokers Dom Maklerski SA
WAR:XTB
|
$3.25 Billion |
|
Runjian Communication Co Ltd Class A
SHE:002929
|
$3.25 Billion |
|
Shenzhen Sed Industry Co Ltd
SHE:000032
|
$3.25 Billion |
|
China Baoan Group Co Ltd
SHE:000009
|
$3.25 Billion |
|
Xiangyang Changyuan Donggu Industry Co Ltd
SHG:603950
|
$3.25 Billion |
|
All Ring Tech Co Ltd
TWO:6187
|
$3.25 Billion |
|
Legend Biotech Corp
NASDAQ:LEGN
|
$3.25 Billion |
|
Navan, Inc. Class A Common Stock
NASDAQ:NAVN
|
$3.24 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MiniMed Group, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,448,000,000 to 3,331,000,000, a change of -117,000,000 (-3.4%).
- Net loss of 250,000,000 reduced equity.
- Other comprehensive income increased equity by 19,000,000.
- Other factors increased equity by 114,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-250.00 Million | -7.51% |
| Other Comprehensive Income | $19.00 Million | +0.57% |
| Other Changes | $114.00 Million | +3.42% |
| Total Change | $- | -3.39% |
Book Value vs Market Value Analysis
This analysis compares MiniMed Group, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.98x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2024-04-30 | $12.28 | $11.57 | x |
| 2025-04-30 | $11.86 | $11.57 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MiniMed Group, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -7.51%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -9.21%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 1.26x
- Recent ROE (-7.51%) is below the historical average (-5.38%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2024 | -3.25% | -4.54% | 0.60x | 1.19x | $-456.80 Million |
| 2025 | -7.51% | -9.21% | 0.65x | 1.26x | $-583.10 Million |
Industry Comparison
This section compares MiniMed Group, Inc. Common Stock's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $182,105,179
- Average return on equity (ROE) among peers: -198.71%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $3.74 Billion | -3.25% | 0.13x | $3.25 Billion |
| Aclarion Inc (ACON) | $-1.70 Million | 0.00% | 0.00x | $1.85 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $90.87 Million |
| Heartbeam Inc (BEAT) | $-2.76 Million | 0.00% | 0.00x | $30.65 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $2.59 Million | -206.61% | 0.07x | $6.51 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $735.38 Million | 2.83% | 5.18x | $8.82 Billion |
| Carlsmed, Inc. Common Stock (CARL) | $-70.63 Million | 0.00% | 0.00x | $261.97 Million |
| CareCloud Inc. (CCLD) | $359.67K | 130.65% | 6.89x | $100.28 Million |
| Certara Inc (CERT) | $822.13 Million | -6.01% | 0.54x | $1.00 Billion |
| CareMax Inc (CMAX) | $3.88 Million | 89.46% | 1.17x | $381.50 |
| Claritev Corporation (CTEV) | $84.02 Million | -1958.81% | 60.30x | $277.75 Million |
About MiniMed Group, Inc. Common Stock
Minimed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin t… Read more